Authors:
Virgolini, I
Patri, P
Novotny, C
Traub, T
Leimer, M
Fuger, B
Li, SR
Angelberger, P
Raderer, M
Wogritsch, S
Kurtaran, A
Kletter, K
Dudczak, R
Citation: I. Virgolini et al., Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy, ANN ONCOL, 12, 2001, pp. S41-S45
Authors:
Virgolini, I
Traub, T
Leimer, M
Novotny, C
Pangerl, T
Ofluoglu, S
Halvadjieva, E
Smith-Jones, P
Flores, J
Li, SR
Angelberger, P
Havlik, E
Andreae, F
Raderer, M
Kurtaran, A
Niederle, B
Dubczak, R
Citation: I. Virgolini et al., New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy, Q J NUCL M, 44(1), 2000, pp. 50-58
Authors:
Kurtaran, A
Becherer, A
Pfeffel, F
Muller, C
Traub, T
Schmaljohann, J
Kaserer, K
Raderer, M
Schima, W
Dudczak, R
Kletter, K
Virgolini, I
Citation: A. Kurtaran et al., F-18-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver, LIVER, 20(6), 2000, pp. 487-490
Authors:
Kurtaran, A
Ofluoglu, S
Traub, T
Tribl, B
Speiser, P
Grabenwoger, F
Schima, W
Dudczak, R
Virgolini, I
Citation: A. Kurtaran et al., An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: Usefulness of hepatobiliary imaging for differential diagnosis, AM J GASTRO, 95(5), 2000, pp. 1367-1368
Authors:
Smith-Jones, PM
Bischof, C
Leimer, M
Gludovacz, D
Angelberger, P
Pangerl, T
Peck-Radosavljevic, M
Hamilton, G
Kaserer, K
Kofler, A
Schlagbauer-Wadl, H
Traub, T
Virgolini, I
Citation: Pm. Smith-jones et al., DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy, ENDOCRINOL, 140(11), 1999, pp. 5136-5148